Pechersky A V
North-West State Medical University named after I.I. Mechnicov, St. Petersburg, Russia.
J Stem Cells. 2016;11(2):99-109.
With age the quantity of pluripotent stem cells gradually decreases. It leads to violation of renewal of tissues, including tissues of endocrine organs, at people over 35-40 years old. Artificial formation of the chimeral individual may be used for recovery of the pool of pluripotent stem cells in patients older than 40-50 years old. Transfusions of mononuclear fraction of peripheral blood procured from young donors 18-23 years old with the same blood groups and sex as the recipient (patent of the Russian Federation № 2350340), allows people over 40 years old to reestablish the pool of pluripotent stem cells, the process of tissue renewal and the production of sex hormones, and can also be seen as a promising way to reduce biological age, while providing a significant prolongation of life and while maintaining a high quality of life. Transfusions of mononuclear fraction of peripheral blood are required to be carried out multiple times before the restoration of the numerical strength of the recipients' pool of pluripotent stem cells is complete. The effectiveness of regeneration reconstitution in individuals older than 40 years old upon receiving transfusions of allogeneic pluripotent stem cells depends on the difference in age between the recipient and the young donor. When there is a major difference in age between young donors and recipients over 40 years old, the proliferative potential of pluripotent stem cells of donors (their ability to maintain the number of own pool) is higher than the proliferative potential of the recipient. In response to the formation of colony-stimulating growth factors, this leads to the dominance of transfused and formed colonies in the bone marrow of the donor's pluripotent stem cells over the analogous cells of recipients when renewing all of their tissues. The latter occurs mainly due to the donors' stem cells.
随着年龄增长,多能干细胞的数量逐渐减少。这会导致35 - 40岁以上人群的组织更新出现紊乱,包括内分泌器官的组织。对于40 - 50岁以上的患者,人工构建嵌合体个体可用于恢复多能干细胞库。输注来自18 - 23岁年轻供体的外周血单核细胞组分,其血型和性别与受体相同(俄罗斯联邦专利 № 2350340),能使40岁以上的人重建多能干细胞库、组织更新过程以及性激素的分泌,还可被视为一种有前景的降低生物学年龄的方法,同时能显著延长寿命并维持较高的生活质量。在外周血单核细胞组分的输注完成受体多能干细胞库数量恢复之前,需要多次进行。40岁以上个体接受同种异体多能干细胞输注后再生重建的有效性取决于受体与年轻供体之间的年龄差异。当年轻供体与40岁以上受体的年龄差异较大时,供体多能干细胞的增殖潜能(其维持自身细胞库数量的能力)高于受体的增殖潜能。在集落刺激生长因子形成的作用下,这会导致在更新所有组织时,供体多能干细胞在受体骨髓中形成的集落比受体自身类似细胞形成的集落占优势。后者主要是由于供体的干细胞导致的。